Patents by Inventor David M. BREESE

David M. BREESE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Torque-equalizing fault response for loss of low voltage DC electrical power in electric vehicle
    Patent number: 12240332
    Abstract: An illustrative dual power inverter module includes a detection circuit configured to detect loss of low voltage DC electrical power supplied to a controller for a first power inverter and a second power inverter of a drive unit for an electric vehicle. A first backup power circuit is associated with the first power inverter and a second backup power circuit is associated with the second power inverter. Each backup power circuit is configured to convert high voltage DC electrical power to low voltage DC electrical power responsive to detection of loss of low voltage DC electrical power supplied to the controller. Three-phase short circuitry is configured to apply a same fault action to the first power inverter and the second power inverter responsive to detection of loss of low voltage DC electrical power supplied to the controller, wherein the same fault action includes applying equalized torque to each axle operatively coupled to the drive unit.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: March 4, 2025
    Assignee: Rivian IP Holdings, LLC
    Inventors: Steven E. Schulz, David Tang, Silva Hiti, Richard M. Breese
  • 4-BENZYLSULFONYL-2-BUTENENITRILE
    Publication number: 20160361286
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 4-benzylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 4-benzylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: Joseph P. ST. LAURENT, Gerald S. JONES, David M. BREESE, Scott A. Goodrich
  • Method for treating inflammation and pain
    Patent number: 9439880
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ?-(methylsulfonyl)alkylamine or ?-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ?-(methylsulfonyl)alkylamine or ?-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: September 13, 2016
    Assignee: OLATEC THERAPEUTICS LLC
    Inventors: Joseph P. St. Laurent, Gerald S. Jones, David M. Breese
  • METHOD FOR TREATING INFLAMMATION AND PAIN
    Publication number: 20160158171
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ?-(methylsulfonyl)alkylamine or ?-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ?-(methylsulfonyl)alkylamine or ?-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: December 3, 2015
    Publication date: June 9, 2016
    Inventors: Joseph P. ST. LAURENT, Gerald S. JONES, David M. BREESE